Reverse stock split Stockholders' Equity, Reverse Stock Split Net cash flows used in operating activities Net cash flows used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net loss Net loss and comprehensive loss Nature of the Business and Basis of Presentation [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Summary of Significant Accounting Policies [Abstract] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Accrued/Prepaid Research and Development Expenses Accrued/Prepaid Research and Development Expenses [Policy Text Block] Disclosure of accounting policies for the accrued\prepaid research and development expenses. Prepaid Expenses Prepaid Expenses [Policy Text Block] Disclosure of accounting policies for prepaid expenses. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Collaborative Arrangements Collaborative Arrangement, Accounting Policy [Policy Text Block] Impairment charge on long-lived assets Asset Impairment Charges, Total Assets measured at fair value Assets, Fair Value Disclosure, Total Long-lived assets Assets, Noncurrent, Total Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Hierarchy and NAV [Domain] Machinery and Equipment [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Lab equipment [Member] laboratory Equipment [Member] Liabilities measured at fair value Liabilities, Fair Value Disclosure, Total Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Property and Equipment, Net Property, Plant and Equipment, Policy [Policy Text Block] Fair Value Hierarchy and NAV [Axis] Computer equipment [Member] Computer Equipment [Member] Percentage for disclosing income taxes paid by jurisdiction Threshold for disclosing income taxes paid by jurisdiction Threshold for disclosing income taxes paid by jurisdiction. Stock-Based Compensation Expense Share-Based Payment Arrangement [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Lease term Lessee, Operating Lease, Renewal Term Office equipment [Member] Office Equipment [Member] Summary of Significant Accounting Policies [Line Items] Change in Accounting Estimate [Line Items] Percentage of tax benefit expected to be realized Percentage of tax benefit expected to be realized. Office rent expense Rent Expense Amount of rent expense. Accrued interest or penalties on unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Leasehold improvements [Member] Leasehold Improvements [Member] Property and equipment, net Property, Plant and Equipment, Net, Total Equity Component [Domain] Aggregate price of advisory services Stock-based compensation Share-Based Payment Arrangement, Expense Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Axis] Advisory Services [Member] Engagement Letter [Member] Outstanding shares of common stock Outstanding Shares of Common Stock Percentage The percentage of shares common stock. Advisor [Member] Segments [Axis] Segment Reporting Information, Profit (Loss) [Abstract] Schedule of Significant Segment Expenses [Line Items] Segment Reporting Information [Line Items] Segments [Domain] Segment Reporting [Table] Other expense – direct listing offering costs Other expense – direct listing offering costs Other expense – direct listing offering costs. Lysosomal Storage Disorders Segment [Member] Net loss per share – diluted Earnings Per Share, Diluted, Total Numerator for basic net loss per share Net Income (Loss) Available to Common Stockholders, Basic Numerator Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator for diluted net loss per share Net Income (Loss) Available to Common Stockholders, Diluted, Total Weighted average common shares outstanding Weighted average common shares outstanding – basic Weighted Average Number of Shares Outstanding, Basic Denominator Weighted Average Number of Shares Outstanding, Basic [Abstract] Non-vested restricted stock units [Member] Performance-based awards [Member] Total potentially dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities [Axis] Schedule of Net Loss Per Share Due to their Anti-Dilutive Effect Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Net Loss Per Share [Abstract] Net Loss Per Share [Abstract] Net loss per share: Net Loss Per Share Earnings Per Share [Text Block] Vesting [Domain] Vesting [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restricted stock units outstanding Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Issued shares of common stock Stock Issued During Period, Shares, Issued for Services Share-Based Payment Arrangement [Member] Class of Stock [Axis] Stock-Based Compensation [Abstract] Number of Awards non-vested, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Segment Information Segment Reporting Disclosure [Text Block] Description of operating segment Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Number of Awards non-vested, ending balance Number of Awards non-vested, beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Restricted Stock Units (RSUs) [Member] Research and development expenses Research and Development Expense, Total Number of reportable segment Number of Reportable Segments Segment Information [Abstract] Weighted Average Grant date Fair Value (per share) non-vested, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Number of Awards non-vested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Weighted Average Grant date Fair Value (per share) non-vested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Maxim Group LLC [Member] Stock Based Compensation Related to Incentive Plan [Member] 2025 Plan Share Pool [Member] Two Thousand Twenty Five Plan Share Pool [Member] Research and development expenses (excluding stock compensation) Research and Development Expenses (Excluding Stock Compensation) Represent the amount of research and development expenses excluding stock compensation. General and administrative expenses (excluding stock compensation) General and Administrative Expenses (Excluding Stock Compensation) Represent the amount of general and administrative expenses excluding stock compensation. Paid amount Payment to third statement of work Related Party Transaction, Amounts of Transaction Related Party Transaction [Line Items] Related Parties [Abstract] Schedule of Net Loss Per Share Due to their Anti-dilutive Effect [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Income Taxes [Abstract] Income Taxes Income Tax Disclosure [Text Block] Amendment Flag City Area Code Cover [Abstract] Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Tax provision or benefit Income Tax Expense (Benefit) Commitments and Contingencies [Abstract] Commitments and Contingencies (Abstract) Subsequent Events [Abstract] Food and Drug Administration [Member] License Agreements [Member] Percentage of sublicensee’s net sales Percentage of Sublicensee’s Net Sales The percentage of sublicensee’s net sales. Percentage royalty of net sales Percentage Royalty of Net Sales The percentage of royalty. Product and Service [Axis] Product and Service [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Commitments and Contingencies [Line Items] Loss Contingencies [Line Items] Other expenses Other Expenses Related Party Transaction [Table] Price per shares Shares Issued, Price Per Share Issuance of shares Issuance of common stock (in Shares) Stock Issued During Period, Shares, New Issues Document Quarterly Report Document Transition Report Document Type Current assets: Assets, Current [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Investment financing Investment Owned, Cost Ownership percentage Investment Owned, Net Assets, Percentage Invested amount Investment Owned, Fair Value Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Statement of Cash Flows [Abstract] Common stock, shares outstanding Common Stock, Shares, Outstanding Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Common stock, par value Common Stock, Par or Stated Value Per Share Mstone [Member] Rush [Member] Service Agreement [Member] Adjustments to reconcile net loss to net cash flows used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Cash and cash equivalents, ending Cash and cash equivalents, beginning Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation, Ending Balance Accounts payable Increase (Decrease) in Accounts Payable, Total Changes in assets and liabilities which provided (used) cash: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Statement of Income Location Balances [Axis] Statement of Income Location Balances [Domain] General and Administrative Expenses [Member] Research and Development Expenses [Member] Working capital Working Capital Represents the amount of working capital. Nature of the Business and Basis of Presentation [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Defined Benefit Plan [Table] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Consolidated Entities [Axis] Stockholders’ Equity (Tables) Stock, Class of Stock [Table] Schedule of Depreciation and Amortization over Estimated Useful Lives of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Stockholders’ Equity [Abstract] Schedule of Components Accrued Expenses and Other Current Liabilities [Abstract] Accrued employee-related expenses Employee-related Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Equity Components [Axis] Rush University Medical Center [Member] Rush University Medical Center [Member] Offering amount Offering Cost, Expense Accrued Expenses and Other Current Liabilities [Abstract] Long-Lived Tangible Asset [Domain] Estimated Useful Life Property, Plant and Equipment, Useful Life Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Company issued shares Sale of Stock, Number of Shares Issued in Transaction Average purchase price per share Sale of Stock, Price Per Share Aggregate consideration Aggregate Consideration Amount of aggregate consideration. Aggregate shares Number of aggregate shares of common stock and preferred stock. Percentage of common stock outstanding Common Stock Outstanding Percentage Percentage of common stock outstanding. Schedule of Depreciation and Amortization over Estimated Useful Lives of Property and Equipment, Net [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Table] Property, Plant and Equipment [Abstract] Long-Lived Tangible Asset [Axis] Cash Cash Stockholders’ Equity [Line Items] Class of Stock [Line Items] Common Stock [Member] Common Stock [Member] Common Stock Percentage of subscribed Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Mstone [Member] Mstone Partners Healthcare Limited [Member] Purchase price per share Purchase Price Per Share Price per shares of purchase. Incremental bonus shares Incremental Bonus Shares Numbers of shares incremental bonus. Investors [Member] Investors [Member] Stockholders’ Equity Equity [Text Block] Consolidated Entities [Domain] Accrued Expenses and other current liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Schedule of Components Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Common stock, shares issued Common Stock, Shares, Issued Cash dividends Dividends, Cash, Total Weighted average recognized service period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Stock-Based Compensation [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Aggregate grant fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Percentage of shares vested upon issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Plan Name [Axis] Fair value was recent stock issuances investors per share Investment Company, Share Issuance, Per Share General and administrative expenses General and Administrative Expense, Total Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Aggregate number of shares issuable Common Stock, Capital Shares Reserved for Future Issuance Class of Stock [Domain] Plan Name [Domain] 2022 Equity Incentive Plan [Member] Two Thousand Twenty Two Equity Incentive Plan [Member] 2025 Equity Incentive Plan [Member] Two Thousand Twenty Five Equity Incentive Plan [Member] Stock Subject To 2025 Plan [Member] Percentage of common stock shares annual Increase Percentage of Common Stock Shares Annual Increase Percentage of common stock shares annual increase. Denominator for basic net loss per share Amount of denominator for basic net loss per share. Denominator for diluted net loss per share Amount of denominator for diluted net loss per share Schedule of Basic and Diluted Net Loss Per Share [Abstract] Schedule of basic and diluted net loss per share [Abstract] Net loss per share – basic Earnings Per Share, Basic, Total Schedule of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Weighted Average Grant date Fair Value (per share) non-vested, Forfeited or exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant date Fair Value (per share) non-vested, ending balance Weighted Average Grant date Fair Value (per share) non-vested, beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance Schedule of Restricted Stock Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of Restricted Stock Activity [Abstract] Number of Awards non-vested, Forfeited or exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Schedule of Significant Segment Expenses Schedule of Segment Reporting Information, by Segment [Table Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] License upfront fee paid License Upfront Fee The amount of license upfront fee. Milestones for a non-orphan indication Milestones for a Non-Orphan Indication The amount of milestones for a non-orphan indication. Milestones for orphan indication Milestones for Orphan Indication The amount of milestones for orphan indication. Percentage of non-royalty consideration Percentage of Non-Royalty Consideration Percentage of non-royalty consideration. Percentage of patent net sales Percentage of Patent Net Sales The percentage of patent net sales. Total current liabilities Liabilities, Current, Total Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Accrued expenses – related party Accrued Liabilities, Current, Total Statement of Financial Position [Abstract] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Total expenses Costs and Expenses, Related Party Due to related party Other Liabilities, Current Related Party [Member] Related Party Income Statement [Abstract] Total operating expenses Operating Expenses, Total Operating expenses: Operating Expenses [Abstract] Operating loss Operating Income (Loss), Total Weighted average common shares outstanding – diluted Weighted Average Number of Shares Outstanding, Diluted Accounts payable Accounts Payable, Current Additional paid-in capital Additional Paid in Capital, Total Total assets Assets, Total Assets Assets [Abstract] Total current assets Assets, Current, Total Cash and cash equivalents Cash and Cash Equivalent, Total Commitments and contingencies (Note 9) Commitments and Contingencies Common stock: $0.0001 par value; 560,000,000 shares authorized; 49,845,993 and 47,343,297 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Total liabilities Liabilities, Total Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Total liabilities and stockholders’ equity Liabilities and Equity, Total Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Related Parties Related Party Transactions Disclosure [Text Block] Subsequent Events Subsequent Events [Text Block] Commitments and Contingencies [Table] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Balance (in Shares) Balance (in Shares) Shares, Outstanding, Ending Balance Issuance of common stock Stock Issued During Period, Value, New Issues Nature of the Business and Basis of Presentation Business Description and Basis of Presentation [Text Block] Accrued expenses – related party Increase decrease in accrued liabilities related party Increase decrease in accrued liabilities related party. Net cash flows provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Stock-based compensation Share-Based Payment Arrangement, Noncash Expense, Total Due to related party Due to related parties Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation, Total Accrued expenses and other current liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Entity Filer Category Entity Incorporation, State or Country Code Entity Interactive Data Current Entity Registrant Name Entity Shell Company Entity Small Business Entity Tax Identification Number Local Phone Number Title of 12(b) Security Security Exchange Name Trading Symbol Current liabilities: Liabilities, Current [Abstract] Other current assets Other Assets, Current Preferred stock: $0.0001 par value, 40,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Prepaid expenses Prepaid Expense, Current, Total Accumulated deficit Retained Earnings (Accumulated Deficit), Total Statement [Line Items] Statement [Table] Common stock, shares authorized Common Stock, Shares Authorized Preferred Stock Preferred Stock [Member] Statement of Stockholders' Equity [Abstract] Balance Balance Total stockholders’ equity Equity, Attributable to Parent, Total Stockholders’ equity: Equity, Attributable to Parent [Abstract] Chief Executive Officer Shorter of remaining life of lease or useful life